IRS 19
  • IRS 19
  • Pack of nasal spray 20ml
  • Price: 12$

IRS 19

For treatment of: Immunostimulants bronchi, respiratory system.

IRS 19 Immunostimulants
  • For the treatment of internal organs: - bronchi, respiratory system
  • Appointment: sinusitis, pharyngitis, tonsillitis, bronchitis, infectious rhinitis, laryngitis, tracheitis
  • Indications for use:
    Prevention of chronic diseases of the upper respiratory tract and bronchi.
    Treatment of acute and chronic diseases of the upper respiratory tract and bronchi, such as rhinitis, sinusitis, laryngitis, pharyngitis, tonsillitis, tracheitis, bronchitis, etc.
    The restoration of local immunity after an influenza and other viral infections.
    Preparation for planned surgery on ENT organs and in the postoperative period.
  • Contraindications:
    Hypersensitivity to the drug or its components in the anamnesis.
    IRS 19 should not be prescribed to patients with autoimmune diseases.
  • Composition:
    Active substances: bacterial lysates - 43.27 ml.
    *Composition of bacterial lysates:
    Streptococcus pneumoniae, type I - 1.11 ml
    Streptococcus pneumoniae, type II - 1.11 ml
    Streptococcus pneumoniae, type III - 1.11 ml
    Streptococcus pneumoniae, type V - 1.11 ml
    Streptococcus pneumoniae, type VIII - 1.11 ml
    Streptococcus pneumoniae, type XII - 1.11 ml
    Haemophilus influenzae, type B - 3.33 ml
    Klebsiella pneumoniae ss pneumoniae - 6.66 ml
    Staphylococcus aureus ss aureus - 9.99 ml
    Acinetobacter calcoaceticus - 3.33 ml
    Moraxella catarrhalis - 2.22 ml
    Neisseria subflava - 2.22 ml
    Neisseria perflava - 2.22 ml
    Streptococcus pyogenes group A - 1.66 ml
    Streptococcus dysgalactiae group C - 1.66 ml
    Enterococcus faecium - 0.83 ml
    Enterococcus faecalis - 0.83 ml
    Streptococcus group G to 1.66 ml
    Excipients: glycine - 4.25 g, sodium mertiolate no more than 1.2 mg, nerol - based flavoring-12.50 mg.